DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Erlinge D, James S, Duvvuru S. , et al.
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.
Thromb Haemost 2014;
111 (05) 943-950
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.